Altay Therapeutics
Altay develops disease-modifying therapies targeting transcription…
Y CombinatorWinter 2020ActiveHealthcareTherapeuticsAI-powered Drug DiscoveryBiotechTherapeuticsDrug discovery
What they do
Problem
Chronic liver diseases such as liver fibrosis and liver cancer lack effective disease-modifying treatments.
Solution
Altay develops novel small-molecule drugs targeting transcription pathways to reduce and potentially reverse liver fibrosis and treat related chronic liver diseases.
Who it's for
Pharmaceutical partners and clinicians treating patients with chronic liver diseases.
Founders
Ali Ozes
Founder
Osman Ozes
Founder
Company timeline
- Founded2019
- YC batchWinter 2020
- StatusActive
- Team size6 people
- LocationSan Francisco, CA, USA; South San Francisco, CA, USA
Similar startups
Pharming Group
Pharming GroupA global biopharmaceutical company developing and comme…
BridgeBio
BridgeBio develops breakthrough medicines for genetic diseases. Its p…
Erasca
Fuck cancer. Every year in the United States, nearly 1.75 million new…
Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
SFA Therapeutics
Regulating the immune system to block cancer & autoimmune diseases
Ochre Bio
RNA medicines for liver diseases